In 2023, it is predicted that the USA animal model market will be worth US$ 976.1 million. From 2023 to 2033, the market for animal models in the USA is anticipated to grow at a 4.3% CAGR. By 2033, it is predicted that the value of the demand for animal models in the US would be US$ 1,487.9 million. In the USA market in 2022, mice held a sizeable proportion of approximately 61.03%, according to a Future Market Insights analysis.
Numerous opportunities have arisen as a result of ongoing developments in the field of personalised medicines. These have made it possible to create patient-centered animal models and will aid in the treatment of numerous ailments. These served to further support the use of animal-based models in the worldwide study and development of precision medicines.
Get your report sample to gain comprehensive insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-14527
Pharmaceutical and biopharmaceutical companies accelerated their use of animal models during the pandemic years to develop diagnostic tools, vaccines, and antiviral medications. Many notable global biomedicine research institutes collaborated with animal model companies based in the United States strengthening their sales during this period.
The United States is seeing a sharp rise in the creation and release of customized medical solutions. This rise may be ascribed to various problems with the unfavorable side effects of some medications. Demand for animal model-based research is being boosted by federal government programs aimed at accelerating the implementation of customized medicine in the nation. In the past, the United States government launched the Precision Medicine Initiative to understand cancer genetics and develop potent treatments for chronic illnesses.
Key Takeaways from the USA Animal Model Market Study Report:
- Back in the year 2017, the demand for animal models in the United States, in terms of value, was nearly 818.7 million.
- Over the next ten years, the animal model market in the United States is projected to witness an absolute growth of US$ 540.6 million.
- Based on different species types, mice are the most preferred models and acquire a market share of 61.03% in the United States.
- Among the different end-user verticals, most of the demand for animal-based models comes from academic and research institutes. This segment generated a revenue of around US$ 352.5 million in 2022, which was figured out to be 37.21% of the market.
Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-14527
Competitive Landscape for the USA Animal Model Market Players:
Key firms in the market are using strategic formulations including forward integration, global expansion, and research alliances to maximize their revenue share and foster business growth. As there are many established participants in the supply of animal models, the overall USA market is fairly distributed and fragmented. However, the market is somewhat consolidated by large investments made by the DARPA and National Institutes of Health in the last few years.
Recent Developments by the Animal Model Industries based in the USA:
- The Jackson Laboratory Inc. reported in February 2020 that a specific hACE2 genetically altered mouse model was available to aid COVID-19 research. This change presented fresh chances to create cutting-edge transgenic mice study models for the best results in clinical studies.
- Charles River Laboratories Inc. and genOway, which is a biotechnology research company that creates transgenic research models, announced their alliance in May 2018. 2000 Ready-to-Use Knockout Mouse Models were to be made available through this agreement for in vivo research projects. The firm was able to strengthen its market position and obtain an edge over others after this strategic relationship.
Key Companies Profiled:
- Charles River Laboratories
- The Jackson Laboratory
- Taconic Biosciences, Inc.
- Genoway
- Envigo (Inotiv, Inc.)
- Marshall BioResources
- Janvier Labs
- Applied stem cells
- Biocytogen
- Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
- Cyagen
- Ingenious targeting labs
- Crown Bioscience Inc. (JSR Corporation).
- Harbour Biomed
- Sinclair BioResources
- Alpha Genesis Inc.
- Creative Animodel
- DaVinci Biomedical Research Products, Inc
Discover the Future of Marketing: Get Your Hands on Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-14527
Key Segments Covered by USA Animal Model Industry Survey Report:
By Species:
- Mice
- Rats
- Fish
- Birds
- Cattles
- Pigs
- Amphibians
- Guinea Pigs
- Dogs
- Cats
- Rabbits
- Monkeys
- Sheep
- Hamsters
- Other Animals
By Technology:
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Microinjection
- Nuclear Transfer
- Other Technologies
By Application:
- Research & Development
- Infectious Disease
- Immunological Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Genetic Diseases
- Neurological Diseases
- Obesity
- NAFLD or NASH
- Renal disease
- Diabetic eye disease
- Fibrosis
- Micro-biome
- Other Research and Developments
- Production and Quality Control
- Academics
- Preclinical Applications
- Infectious Disease
- Immunological Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Genetic Diseases
- Neurological Diseases
- Obesity
- NAFLD/NASH
- Renal disease
- Diabetic eye disease
- Fibrosis
- Micro-biome
- Other Preclinical Applications
- Other Applications
By Use:
- Human
- Veterinary
By End-user Verticals:
- Companies
- Pharmaceutical
- Biotechnology
- Cosmetics
- Other Companies
- Organizations
- Government
- Non-government
- Academic and Research Institutes
- Contract Research Organizations (CRO)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
